← Back to catalogue

Contour®next

FDA UDI

Class III (US FDA UDI)

by Ascensia Diabetes Care Us Inc.

Identity

Trade Name
CONTOUR®NEXT FDA UDI
Generic Name
Glucose monitoring system IVD, home-use FDA UDI
Device Name
Blood glucose test strips. Sold in a carton of 15 test strips. FDA UDI
Model / Reference
7550 FDA UDI
Description
Blood glucose test strips. Sold in a carton of 15 test strips. FDA UDI

Identifiers

Catalog Number
90001174 FDA UDI
Primary DI / UDI-DI
10301937550154 FDA UDI
PMA Number
P150001 FDA UDI
P160017 FDA UDI
510(k) Number
K191286 FDA UDI
K193407 FDA UDI
K210687 FDA UDI
K223293 FDA UDI
K241787 FDA UDI
FDA Product Code
OZP FDA UDI
OZO FDA UDI
NBW FDA UDI
GMDN Term
Glucose monitoring system IVD, home-use FDA UDI

Classification

Device Class
Class III FDA UDI
Regulation Number
862.1345 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

Yes

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Glucose monitoring system IVD, home-use

Contour®next by Ascensia Diabetes Care Us Inc. — Class III — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Glucose monitoring system IVD, home-use.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI c1943aef-2a71-4eb5-a589-890a2ab034de 37 fields · synced Jun 8, 2026